The medicinal potential of black seed (Nigella sativa) and its components

Advances in Phytomedicine

Volumn 2, Issue C, 2006, Pages 133-153

  Gali Muhtasib, Hala ^a   El Najjar, Nahed ^a   Schneider Stock, Regine ^a  

^a NONE

Author keywords

black seed; medicinal plants; N. sativa oil; nigella sativa; thymoquinone

Indexed keywords

EID: 55349146787     PISSN: 1572557X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1572-557X(05)02008-8     Document Type: Review

References (110)

1. Abdel-Fattah A.M., Matsumoto K., and Watanabe H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone in mice. Eur J Pharmacol 400 (2000) 89-97
2. Abdel-Salam I.M., Hassanein A.G., El-Sayed M.M., and Mokhtar N.M. The protective effect of Nigella sativa on bilharzial-induced liver injury in mice. Arab J Lab 19 (1993) 127-138
3. Abou Basha L.I., Rashed M.S., and Aboul-Enein H.Y. TLC assay of thymoquinone in black seed oil (Nigella sativa Linn) and identification of dithymoquinone and thymol. J Liquid Chrom 18 (1995) 105-115
4. Aboul Ela M.A., El-Shaer N.S., and Ghanem N.B. Antimicrobial evaluation and chromatographic analysis of some essential and fixed oils. Pharmazie 51 (1996) 993-994
5. Aboul-Ela E.I. Cytogenetic studies on Nigella sativa seeds extract and thymoquinone on mouse cells infected with schistosomiasis using karyotyping. Mutat Res 516 (2002) 11-17
6. Aboul-Enein Y.H., and Abou-Basha I.L. Simple HPLC method for the determination of thymoquinone in black seed oil (Nigella sativa Linn). J Liquid Chrom 18 (1995) 895-902
7. Aboul-Enein H.Y., Kruk I., and Lichszteld K. Antioxidant action of several β-adrenergic blockers and related compounds. Toxicol Environ Chem 68 (1999) 349-361
8. Aboutabl E.A., El-Azzouny A.A., and Hammerschmidt F.J. Aroma volatiles of Nigella sativa L. seeds. In: Brunke E.J. (Ed). Progress in essential oil research. Proceedings of the 16th International Symposium on essential oils (1986), DeGruyer, Berlin 49-55
9. Agarwal R., Kharya M.D., and Shrivastava R. Antimicrobial and anthelminthic activities of the essential oil of Nigella sativa Linn. Indian J Exp Biol 17 (1979) 1264-1265
10. Akhtar M.S., and Riffat S. Field trial of Saussurea lappa roots against nematodes and Nigella sativa seeds against cestodes in children. J Pak Med Assoc 41 (1991) 185-187
11. Al-Awadi F., Fatania H., and Shamte U. The effect of a plant's mixture extract on liver gluconeogenesis in streptozotocin-induced diabetic rats. Diabetes Res 18 (1991) 163-168
12. Al-Ghamdi M.S. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol 76 (2001) 45-48
13. Al-Gharably N.M., Badary O.A., Nagi M.N., Al-Shabanah O.A., Al-Sawaf H.A., Al-Rikabi A.C., and Al-Bekairi A.M. Protective effect of thymoquinone against carbon tetrachloride-induced hepatotoxicity in mice. Res Commun Pharmacol Toxicol 2 (1997) 41-50
14. Al-Hader A.A., Aqel M.B., and Hasan Z.A. Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Int J Pharmacogn 31 (1993) 96-100
15. Al-Homidan A., Al-Qarawi A.A., Al-Waily S.A., and Adam S.E. Response of broiler chicks to dietary Rhazya stricta and Nigella sativa. Br Poult Sci 43 (2002) 291-296
16. Al-Shabanah O.A., Badary O.A., Nagi M.N., Al-Gharably N.M., Al-Rikabi A.C., and Al-Bekairi A.M. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. J Exp Clin Cancer Res 17 (1998) 193-198
17. Aqel M., and Shaheen R. Effect of the volatile oil of Nigella sativa seeds on the uterine smooth muscle of rat and guinea pig. J Ethnopharmacol 52 (1996) 23-26
18. Badary O.A. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J Ethnopharmacol 1 (1999) 135-142
19. Badary O.A., Abdel-Naim A.B., Abdel-Wahab M.H., and Hamada F.M. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicology 143 (2000) 219-226
20. Badary O.A., Al-Shabanah O.A., Nagi M.N., Al-Bekairi A.M., and Elmazar M.A. Acute and subchronic toxicity of thymoquinone in mice. Drug Dev Res 44 (1998) 56-61
21. Badary O.A., Al-Shabanah O.A., Nagi M.N., Al-Rikabi A.C., and Elmazar M.M. Inhibition of benzo(a)pyrene-induced fore-stomach carcinogenesis in mice by thymoquinone. Eur J Cancer Prev 8 (1999) 435-440
22. Badary O.A., and Gamal El-Din A.M. Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis. Cancer Detect Prev 25 (2001) 362-368
23. Badary O.A., Nagi M.N., Al-Shabanah O.A., Al-Sawaf H.A., Al-Sohaibani M.O., and Al-Bekairi A.M. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol 75 (1997) 1356-1361
24. Bamosa A.O., Ali B.A., and Sowayan S.A. Effect of oral ingestion of Nigella sativa seeds on some blood parameters. Saudi Pharm J 5 (1997) 126-129
25. Bertani T., Cutillo F., Zoja C., Broggini M., and Remuzzi G. Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30 (1986) 488-496
26. Boulos L. Medicinal plants of North Africa (1983), Reference Publications, Algonac, MI p. 103
27. Brade W.P., Seeber S., and Herdrich K. Comparative activity of ifosfamide and cyclophosphamide. Cancer Chemother Pharmacol 18 (1986) S1-S9
28. Burits M., and Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res 14 (2000) 323-328
29. Chakravarty N. Inhibition of histamine release from mast cells by nigellone. Ann Allergy 70 (1993) 237-242
30. Chopra R.N., Nayar S.L., and Chopra I.C. Glossary of Indian medicinal plants (1956), CSIR, New Delhi p. 175
31. Cortes E.P., Lutman G., Wanta J., Pickren J., Wallace J., and Holland J. Adriamycin (NSC 123127) cardiotoxicity: a clinicopathologic correlation. Cancer Chemother Rep 6 (1975) 215-225
32. Daba M.H., and Abdel-Rahman M.S. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol Lett 16 (1998) 23-29
33. De Smet P.A.G.M. The role of plant-derived drugs and herbal medicines in health care. Drugs 54 (1997) 801-840
34. Dubick M.A. Historical perspectives on the use of herbal preparations to promote health. J Nutr 116 (1986) 1348-1354
35. El-Dakhakhny M. Studies on the chemical constitution of the Egyptian Nigella sativa L. seeds. II: The essential oil. Planta Medica, 12 (1963) 465-470
36. El-Dakhakhny M. Studies on the Egyptian Nigella sativa L. IV Some pharmacological properties of seeds active principle in comparison to its dihydro compound and its polymer. Arzneim Forsch (Drug Res Germ) 15 (1965) 1227-1229
37. El-Dakhakhny M., El-Halim M., Aly S.M., and Barakat M.K. Protective effect of Nigella sativa oil and clindamycin against production of TNF-α and liver injury in murine septic peritoritis. Naunyn Schmiedeberg's Arch Pharmacol 362 (2000) R17 (abstract no. 12)
38. El-Dakhakhny M., Barakat M., Abdel El-Halim M., and Aly S.M. Effects of Nigella sativa oil on gastric secretion and ethanol-induced ulcer in rats. J Ethnopharmacol 72 (2000) 299-304
39. El-Dakhakhny M., Mady N.I., and Halim M.A. Nigella sativa L. oil protects against induced hepatotoxicity and improves serum lipid profile in rats. Arzneim Forsch 50 (2000) 832-836
40. El-Dakhakhny M., Mady N.J., Lembert N., and Ammon H.P. Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J Ethnopharmacol 81 (2002) 161-164
41. El-Dakhakhny M., Mady N., Lembert N., and Ammon H.P. The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Med 68 (2002) 465-466
42. El-Dakhakhany M. Some pharmacological properties of some constituents of Nigella sativa L. seeds. The carbonyl fraction of the essential oil. Proceedings of the Second International Conference on Islamic Medicine, 12th April (1982), Studies in Islamic Medicine and Advantages of Herbal treatment, Kuwait 246-431
43. El-Daly E.S. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J Pharmacol (Belgium) 53 (1998) 87-93
44. El-Fatatry H.M. Isolation and structure assignment of an antimicrobial principle from the volatile oil of Nigella sativa L seeds. Pharmazie 30 (1975) 109-111
45. El-Kadi A., and Kandil O. Effect of Nigella sativa (the black seeds) on immunity. Proceedings of the Fourth International Conference on Islamic Medicine. Bull. Islamic Med, 4 (1986) 344-348
46. El-Kadi A., Kandil O., and Tabuni A.M. Nigella cell-mediated immunity. Arch AIDS Res 1 (1987) 232-233
47. El-Mahmoudy A., Matsuyama H., Borgan M.A., Shimizu Y., El-Sayed M.G., Minamoto N., and Takewaki T. Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. Int Immunopharmacol 2 (2002) 1603-1611
48. El-Tahir K.E., Ashour M.M., and Al-Harbi M.M. The respiratory effects of the volatile oil of the black seed (Nigella sativa) in guinea pigs: elucidation of the mechanism(s) of action. Gen Pharmacol 24 (1993) 1115-1122
49. El-Tahir K.E., Ashour M.M., and Al-Harbi M.M. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. Gen Pharmacol 24 (1993) 1123-1131
50. Enomoto S., Asano R., Iwahori Y., Narui T., Okada Y., Singab A.N., and Okuyama T. Hematological studies on black cumin oil from the seeds of Nigella sativa L. Biol Pharm Bull 24 (2001) 307-310
51. Fararh K.M., Atoji Y., Shimizu Y., and Takewaki T. Insulinotropic properties of Nigella sativa oil in streptozotocin plus nicotinamide diabetic hamster. Res Vet Sci 73 (2002) 279-282
52. Fernandez E.R., Carvalho F.D., Remiao F.G., Bastos M.L., Pinto M.M., and Gottlieb O.R. Hepatoprotective activity of xanthones and xanthonolignoids against tert-butylhydroperoxide-induced toxicity in isolated hepatocytes - comparison with silybin. Pharmacol Res 12 (1995) 1756-1760
53. Gali-Muhtasib H., Diab-Assaf M., Boltze C., Al-Hmaira J., Hartig R., Roessner A., and Schneider-Stock R. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol 25 4 (2004) 857-866
54. Ghazanfer S.A. Handbook of Arabian medicinal plants (1994), CRC Press, Boca Raton, FL p. 180
55. Ghoneim MT, El-Gindy AR, El-Alami E, Shoukry R, Yaseen S. (1982) Possible effect of some extracts of Nigella sativa L. seeds on blood coagulation system and fibrinolytic activity. Proceedings of the Second International Conference on Islamic Medicine, Kuwait, 12th April.
56. Ghosheh O.A., Houdi A.A., and Crooks P.A. High-performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed. J Pharm Biomed Anal 19 (1999) 757-762
57. Gilani A.H., Aziz N., Khurram I.M., Chaudhary K.S., and Iqbal A. Bronchodilator, spasmolytic and calcium antagonist activities of Nigella sativa seeds (Kalonji): a traditional herbal product with multiple medicinal uses. J Pak Med Assoc 51 (2001) 115-120
58. Hanafy M.S., and Hatem M.E. Studies on the antimicrobial activity of Nigella sativa seed (black cumin). J Ethnopharmacol 34 (1991) 275-278
59. Haq A., Adbullatif M., Labo P., Khabar K., Sheth K., and AlSedairy S. Nigella sativa: effect on human lymphocytes and polymorphonuclear leucocyte phagocytic activity. Immunopharmacology 30 (1995) 147-155
60. Haq A., Lobo P.I., Al-Tufail M., Rama N.R., and Al-Sedairy S.T. Immunomodulatory effect of Nigella sativa proteins fractionated by ion exchange chromatography. Int J Immunopharmacol 21 (1999) 283-295
61. Hashem F.M., and El-Kiey M.A. Nigella sativa seeds of Egypt. J Pharm Sci United Arab Republic 3 (1982) 121-133
62. Hassan M., and El-Dakhakhny M. Effect of some Nigella sativa constituents on chemical carcinogenesis in hamster cheek pouch. J Egyptian Soc PharmacolExp Therap 11 (1992) 675-677
63. 2-induced hepatocyte plasma membrane bleb formation by certain prostaglandins and a proteinase inhibitor. Biochim Biophys Acta 1022 (1990) 319-324
64. Hossain S., Takimoto H., Hamano S., Yoshida H., Ninomiya T., Minamishina Y., Kimura G., and Nomoto K. Protective effects of hochu-ekki-to, a Chinese traditional herbal medicine against murine cytomegalovirus infection. Immunopharmacology 41 (1999) 169-181
65. Houghton P.J., Zarka R., De las Heras B., and Hoult R.S. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Medica 61 (1995) 33-36
66. Huxtable R.J. The pharmacology of extinction. J Ethnopharmacol 37 (1992) 1-11
67. Jansen PCM. (1981) Spices, condiments and medicinal plants in Ethiopia, their taxonomy and agricultural significance. Addis Ababa: Center for Agricultural Publishing and Documentation, pp. 76-85.
68. Khan M.A. Chemical composition and medicinal properties of Nigella sativa Linn. Inflammopharmacology 7 (1999) 15-35
69. Kiso Y., Tohkin M., Hikine H., Hattori M., Sakamoto T., and Namba T. Mechanism of antihepatotoxic activity of glycerrhizin. Effect of free radical generation and lipid peroxidation. Planta Med 50 (1984) 298-302
70. Kruk I., Michalska T., Lichszteld K., Kladna A., and Aboul-Enein H.Y. The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere 41 (2000) 1059-1064
71. Kumara S.S., and Huat B.T. Extraction, isolation and characterisation of antitumor principle, α-hederin, from the seeds of Nigella sativa. Planta Med 67 (2001) 29-32
72. Labhal A., Settaf A., Bennani-kabchi N., Cherrah Y., Slaoui A., and Hassar M. Actio anti-obesite, hypocholesterolemiante et hypotriglyceridemiante de Nigella sativa chez le Psammomys obesus. Caducee 27 (1997) 26-28
73. Mabrouk G.M., Moselhy S.S., Zohny S.F., Ali E.M., Helal T.E., Amin A.A., and Khalifa A.A. Inhibition of methylnitrosourea (MNU)-induced oxidative stress and carcinogenesis by orally administered bee honey and Nigella grains in Sprague Dawley rats. J Exp Clin Cancer Res 21 (2002) 341-346
74. Mahfouz M., Abdel Maguid R., and El-Dakhakhny M. Effectiveness of nigellone in asthma in adults. Alexandria Med J 6 (1960) 543-547
75. Mahfouz M., Abdel-Maguid R., and El-Dakhakhny M. The effect of ''nigellone therapy'' on the histaminopexic power of the blood sera in asthmatic patients. Arzneim Forsch (Drug Res.), 15 (1965) 1230-1234
76. Mahfouz M., and El-Dakhakhny M. The isolation of a crystalline active principle from Nigella sativa L. seeds. J Pharm Sci United Arab Republic 1 (1960) 9-19
77. Mahmoud M.R., El-Abhar H.S., and Saleh S. The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. J Ethnopharmacol 79 (2002) 1-11
78. Mansour M.A. Protective effects of thymoquinone and desferrioxamine against hepatotoxicity of carbon tetrachloride in mice. Life Sci. 66 (2000) 2583-2591
79. Mansour M.A., Nagi M.N., El-Khatib A.S., and Al-Bekairi A.M. Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action. Cell. Biochem. Funct. 20 (2002) 143-151
80. Masaki N., Kyle M.E., and Farber J.L. Tert-butyl hydroperoxide kills cultured hepatocytes by peroxidizing membrane lipids. Arch Biochem Biophys 269 (1989) 390-399
81. Meral I., Yener Z., Kahraman T., and Mert N. Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defence system and liver damage in experimentally induced diabetic rabbits. J Vet Med A Physiol Pathol Clin Med 48 (2001) 593-599
82. Miguez M., Anundi I., Sainz-Pardo L., and Lindros K.O. Hepatoprotective mechanism of silymarin: no evidence for involvement of cytochrome P450 2EI. Chem Biol Interact. 91 (1994) 51-63
83. Morsi N.M. Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta Microbiol Pol 49 (2000) 63-74
84. Nadkarni K. Crocus sativus, Nigella sativa. In: Nadkarni K.M. (Ed). Indian materia medica (1976), Popular Prakashan, Bombay, India 386-411
85. Nagi M.N., Alam K., Badary O.A., Al-Shabanah O.A., Al-Sawaf H.A., and Al-Bekairi A.M. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int 47 (1999) 153-159
86. Nagi M.N., and Mansour M.A. Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol Res 41 (2000) 283-289
87. Nair S.C., Salomi M.J., Panikkar B., and Panikkar K.R. Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice. J Ethnopharmacol 31 (1991) 75-83
88. Navaro M.C., Montilla M.P., Martin A., Jimenez J., and Utrilla M.P. Free radical scavenger and antihepatotoxic activity of Rosemarinus tomentosus. Planta Med 53 (1993) 312-314
89. Reynolds P., Rahija J., Schenkman I., and Richter B. Experimental murine cytomegalovirus infection in severe combined immunodeficient mice. Lab Anim Sci 43 (1993) 291-295
90. Salem M.L., and Hossain M.S. Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection. Int J Immunopharmacol 22 9 (2000) 729-740
91. Salomi N.J., Nair S.C., and Panikkar K.R. Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nut Cancer 16 (1991) 67-72
92. Salomi N.J., Nair S.C., Jayawardhanan K.K., Varghese C.D., and Panikkar K.R. Antitumour principles from Nigella sativa seeds. Cancer Lett 31 (1992) 41-46
93. Saxena A., and Vyas K. Antimicrobial activity of seeds of some ethnopharmacinal plants. J Econ Taxon Botany 8 (1986) 291-299
94. Shertzer H.G., Bannenberg H., Zhu R.M., and Moldeus P. The role of thiols in mitochondrial susceptibility to iron and tert-butyl hydroperoxide-mediated toxicity in cultured hepatocytes. Chem Res Toxicol 7 (1994) 358-366
95. Shoieb A.M., Elgayyar M., Dudrick P.S., Bell J.L., and Tithof P.K. In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol 22 (2003) 107-113
96. Smith A., and Brennessel J. Cytomegalovirus. Infect Dis Clin North Am 8 (1994) 427-438
97. Steinmann A., Schatzle M., Agathos M., and Breit R. Allergic contact dermatitis from black cumin (Nigella sativa) oil after topical use. Contact Dermatitis 36 (1997) 268-269
98. Swamy S.M., and Tan B.K. Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L seeds. J Ethnopharmacol 70 (2000) 1-7
99. Tennekoon K., Jeevathayaparan S., Kurukulasooriya A., and Karunanayake E. Possible hepatotoxicity of Nigella sativa seeds and Dregea volubilis leaves. J Ethnopharmacol 31 (1991) 283-289
100. Thabrew M.I., Gove C.D., Hughes R.D., McFarlane I.G., and Williams R. Protective effects of Osbeckia octandra against galactosamine and tert-butyl hydroperoxide-induced hepatocyte damage. J Ethnopharm 49 (1995) 69-76
101. Topozada H.H., Mazolum H.A., and El-Dakhakhny M. The antibacterial properties of Nigella sativa seeds. Active principle with some clinical applications. J Egypt Med Assoc 48 (1965) 187-202
102. ur-Rahman A., Malik S., Cunheng H., and Clardy J. Isolation and structure of determination of nigellicine, a novel alkaloid from the seeds of Nigella sativa. Tetrahedron Lett 26 (1985) 2759-2762
103. Valenzuela A., Guera R., and Videla L.A. Antioxidant properties of the flavonoids silybin and +{plus 45 degree rule}- cyanidanol-3: comparison with butylated hydroxyanisole and butylated hydroxytoluene. Planta Med 52 (1986) 438-440
104. Vogel G. Natural substances with effects on the liver. In: Wagner H., and Wolff P. (Eds). New natural products and plant drugs with pharmacological, biological or therapeutic activity (1977), Springer, New York 249-263
105. Worthen D., Ghosheh O., and Crooks P. The in vitro anti-tumor activity of some crude and purified components of black seed, Nigella sativa L. Anticancer Res 18 (1998) 1527-1532
106. Zaoui A., Cherrah Y., Alaoui K., Mahassine N., Amarouch H., and Hassar M. Effects of Nigella sativa fixed oil on blood homeostasis in rat. J Ethnopharmacol 79 (2002) 23-26
107. Zaoui A., Cherrah Y., Lacaille-Dubois M.A., Settaf A., Amarouch H., and Hassar M. Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie 5 (2000) 379-382
108. Zaoui A., Cherrah Y., Mahassini N., Alaoui K., Amarouch H., and Hassar M. Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine 9 (2002) 69-74
109. Zedlitz S., Kaufmann R., and Boehncke W.H. Allergic contact dermatitis from black cumin (Nigella sativa) oil-containing ointment. Contact Dermatitis 46 (2002) 188
110. Zima T., Tesar V., Stipek S., Crkovska J., Poledne R., Teminova J., Platenik J., Rychlik I., Merta M., and Nemecek K. The influence of cyclosporin on lipid peroxidation and superoxide dismutase in adriamycin nephropathy in rats. Nephron 75 (1997) 464-468